Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04088773 · ClinicalTrials.gov registry record
Biomarkers of Intestinal Fibrosis in Small Bowel Crohn's Disease
A clinical trial of Crohn Disease, sponsored by Children's Hospital Medical Center, Cincinnati.
- Active
- Registry status
- 232
- Enrollment target
- 4
- Study locations
NCT04088773 is a study of Crohn Disease that is active but no longer recruiting, run by Children's Hospital Medical Center, Cincinnati. The registered enrollment target is 232 participants, above the 202-participant average among 71 other Crohn Disease trials with a reported enrollment target (15% higher). The trial reports 4 study locations across 4 states.
The verdict
NCT04088773, a study of Crohn Disease, is active but no longer recruiting, sponsored by Children's Hospital Medical Center, Cincinnati.
- ACTIVE NOT RECRUITING
- Registry status
- 232 participants
- Enrollment target
- 4
- Study locations
Study Summary
This research study will evaluate if specific blood, stool and MRI tests can tell the difference between bowel wall inflammation without scarring and bowel wall inflammation with scarring that can cause bowel blockages requiring surgery.
Conditions Studied
Interventions
- DIAGNOSTIC_TEST blood biomarkers
- DIAGNOSTIC_TEST stool biomarkers
- DIAGNOSTIC_TEST MRI imaging
Study Locations (4)
Georgia
- Emory/Children's Healthcare of Atlanta - Atlanta
Michigan
- Michigan Medicine - Ann Arbor
Minnesota
- Mayo Clinic - Rochester
Ohio
- Cincinnati Children's Hospital Medical Center - Cincinnati
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 232 participants |
| Start Date | 2019-11-01 |
| Est. Completion | 2026-06 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04088773
The ClinicalTrials.gov registry entry for NCT04088773 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 232 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 202-participant average among 71 other Crohn Disease trials with a reported enrollment target (15% higher). The listed sponsor is Children's Hospital Medical Center, Cincinnati, which has 571 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Crohn Disease appearing as the primary indexed condition, and to 3 interventions - of which blood biomarkers is the first listed.
NCT04088773 reports 4 study locations spanning 4 distinct geographic areas - top geographies include Georgia, Michigan, Minnesota.
Frequently Asked Questions
What is clinical trial NCT04088773 about?
NCT04088773 is a clinical study titled "Biomarkers of Intestinal Fibrosis in Small Bowel Crohn's Disease". This research study will evaluate if specific blood, stool and MRI tests can tell the difference between bowel wall inflammation without scarring and bowel wall inflammation with scarring that can cause bowel blockages requiring surgery.
What is the current status of trial NCT04088773?
This trial is currently active not recruiting. The enrollment target is 232 participants. The study started on 2019-11-01. Estimated completion is 2026-06.
What conditions does trial NCT04088773 study?
This clinical trial studies the following conditions: Crohn Disease.
What interventions are being tested in trial NCT04088773?
The interventions under investigation include: blood biomarkers (DIAGNOSTIC_TEST), stool biomarkers (DIAGNOSTIC_TEST), MRI imaging (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT04088773?
This trial is sponsored by Children's Hospital Medical Center, Cincinnati, which has 571 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04088773 being conducted?
This trial has 4 study locations across Georgia, Michigan, Minnesota, Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Crohn Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Stelara and Tremfya Pregnancy Exposure Registry OTIS Autoimmune Diseases in Pregnancy Project
RECRUITING
-
Nivolumab in Treating Patients With Autoimmune Disorders and Advanced, Metastatic, or Unresectable Cancer
RECRUITING · Phase 1
-
Treat-to-Target of Endoscopic Remission in Patients With IBD in Symptomatic Remission
RECRUITING · NA
-
Low Dose IL-2 for the Treatment of Crohn's Disease
RECRUITING · Phase 1
-
Registry and Biorepository for IBD in Central Texas
RECRUITING
-
VECTORS - A Study to Evaluate Transmural Healing as a Treatment Target in Crohn's Disease
RECRUITING · Phase 4
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.